IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $229,000 | -56.6% | 11,975 | -44.1% | 0.14% | -58.6% |
| Q3 2021 | $528,000 | -4.2% | 21,430 | +1.3% | 0.33% | -2.4% |
| Q2 2021 | $551,000 | +66.5% | 21,159 | +102.5% | 0.33% | +42.1% |
| Q1 2021 | $331,000 | +28.3% | 10,450 | +88.3% | 0.24% | -3.7% |
| Q4 2020 | $258,000 | +15.7% | 5,550 | -18.1% | 0.24% | +5.2% |
| Q3 2020 | $223,000 | -8.6% | 6,775 | -23.7% | 0.23% | -6.5% |
| Q2 2020 | $244,000 | +14.6% | 8,875 | +25.0% | 0.25% | -2.7% |
| Q1 2020 | $213,000 | – | 7,100 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |